Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Reference33 articles.
1. Emerging cytokine targets in rheumatoid arthritis;Asquith;Curr Opin Rheumatol,2007
2. Joint inflammation and cytokine inhibition in rheumatoid arthritis;Christodoulou;Clin Exp Med,2006
3. Pathogenesis of rheumatoid arthritis: targeting cytokines;Zwerina;Ann N Y Acad Sci,2005
4. New therapies for treatment of rheumatoid arthritis;Smolen;Lancet,2007
5. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases;Kumar;Nat Rev Drug Discov,2003
Cited by 207 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Remodeling tumor‐associated macrophage for anti‐cancer effects by rational design of irreversible inhibition of mitogen‐activated protein kinase‐activated protein kinase 2;MedComm;2024-07
2. VX-702 Ameliorates the Severity of Sepsis-Associated Acute Kidney Injury by Downregulating Inflammatory Factors in Macrophages;Journal of Inflammation Research;2024-06
3. Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review;ACS Pharmacology & Translational Science;2024-05-28
4. Posttranslational protein modifications as gatekeepers of cancer immunogenicity;Journal of Clinical Investigation;2024-05-15
5. MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution;Journal of Clinical Investigation;2024-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3